Crocs (CROX) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

08.05.25 15:30 Uhr

Werte in diesem Artikel
Aktien

94,21 EUR 6,24 EUR 7,09%

Crocs (CROX) reported $937.33 million in revenue for the quarter ended March 2025, representing a year-over-year decline of 0.1%. EPS of $3.00 for the same period compares to $3.02 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $909.56 million, representing a surprise of +3.05%. The company delivered an EPS surprise of +19.52%, with the consensus EPS estimate being $2.51.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.Here is how Crocs performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Revenues- Crocs Brand: $761.61 million compared to the $744.37 million average estimate based on three analysts. The reported number represents a change of +2.4% year over year. Revenues- HEYDUDE Brand: $175.73 million compared to the $166.55 million average estimate based on three analysts. The reported number represents a change of -9.8% year over year. Revenues By Channel- HEYDUDE Brand- Wholesale: $110.69 million compared to the $105.40 million average estimate based on two analysts. Revenues By Channel- Crocs Brand- Direct-to-Consumer: $284.80 million versus $279.37 million estimated by two analysts on average. Revenues By Channel- HEYDUDE Brand- Direct-to-Consumer: $65.03 million versus $61.63 million estimated by two analysts on average. Revenues By Channel- Crocs Brand- Wholesale: $476.80 million compared to the $467.14 million average estimate based on two analysts. Non-GAAP Gross Margin- HEYDUDE Brand: 46.6% versus 47.9% estimated by two analysts on average. Non-GAAP Gross Margin- Crocs Brand: 60.7% versus the two-analyst average estimate of 58.3%. View all Key Company Metrics for Crocs here>>>Shares of Crocs have returned +1.2% over the past month versus the Zacks S&P 500 composite's +11.3% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.7 Best Stocks for the Next 30 DaysJust released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops."Since 1988, the full list has beaten the market more than 2X over with an average gain of +23.9% per year. So be sure to give these hand picked 7 your immediate attention. See them now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Crocs, Inc. (CROX): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: CROCS und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.

Ausgewählte Hebelprodukte auf CROCS

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf CROCS

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu CROCS Inc.

Wer­bung

Analysen zu CROCS Inc.

DatumRatingAnalyst
28.02.2019CROCS BuyMonness, Crespi, Hardt & Co.
15.01.2019CROCS BuyPivotal Research Group
09.11.2018CROCS BuyPivotal Research Group
06.11.2018CROCS BuyPivotal Research Group
25.07.2018CROCS BuyPivotal Research Group
DatumRatingAnalyst
28.02.2019CROCS BuyMonness, Crespi, Hardt & Co.
15.01.2019CROCS BuyPivotal Research Group
09.11.2018CROCS BuyPivotal Research Group
06.11.2018CROCS BuyPivotal Research Group
25.07.2018CROCS BuyPivotal Research Group
DatumRatingAnalyst
02.05.2018CROCS HoldPivotal Research Group
10.01.2018CROCS HoldPivotal Research Group
10.11.2016CROCS NeutralMonness, Crespi, Hardt & Co.
03.01.2012CROCS neutralRobert W. Baird & Co. Incorporated
19.10.2011CROCS neutralD.A. Davidson & Co.
DatumRatingAnalyst
18.09.2006Update CROCS Inc.: SellMatrix Research

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für CROCS Inc. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen